OM-DOM CAP is a fixed-dose combination of Omeprazole and Domperidone, designed to treat acid reflux, heartburn, and functional dyspepsia. Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion, while Domperidone is a prokinetic agent that enhances gastrointestinal motility and prevents nausea. This dual-action formula is ideal for comprehensive treatment of gastroesophageal reflux disease (GERD), and is manufactured to global quality standards by Bluepill Express for third-party and export purposes.

This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

OM-DOM CAP is a highly effective gastrointestinal therapy that combines two pharmacological agents: Omeprazole, a potent proton pump inhibitor (PPI), and Domperidone, a dopamine antagonist with strong prokinetic and antiemetic properties. This combination is specially formulated to address multiple aspects of upper gastrointestinal distress, including acid reflux, nausea, bloating, indigestion, and gastric motility disorders.

Omeprazole, the primary component of OM-DOM CAP, works by inhibiting the gastric proton pump enzyme H+/K+ ATPase located in the stomach lining. This action effectively reduces acid secretion and creates a less acidic gastric environment, allowing healing of esophageal and gastric tissues affected by excess acid. Omeprazole is widely used in the treatment of GERD, peptic ulcers, erosive esophagitis, and conditions involving hyperacidity.

Domperidone, the second component, complements the acid-suppressing action of Omeprazole by improving gastric motility and accelerating gastrointestinal emptying. It also exhibits anti-nausea properties by blocking dopamine receptors in the chemoreceptor trigger zone, making it useful in the treatment of nausea, vomiting, and bloating. Domperidone enhances the lower esophageal sphincter tone, helping to prevent reflux.

Together, Omeprazole and Domperidone offer a synergistic solution to acid-peptic disorders and dyspepsia that are often resistant to monotherapy. OM-DOM CAP is therefore indicated in GERD with associated nausea, chronic gastritis, functional dyspepsia, and post-meal fullness.

Manufactured by Bluepill Express under strict international standards including WHO-GMP, ISO, and FDA-equivalent regulatory compliance, OM-DOM CAP undergoes comprehensive testing for quality control, uniformity, stability, and microbial contamination. Each capsule is produced in state-of-the-art manufacturing facilities equipped with modern machinery and validated processes.

OM-DOM CAP is typically offered in 20 mg Omeprazole + 10 mg Domperidone dosage strength, though other strengths can be customized upon request. It is available in blister or alu-alu packaging, with options for bulk supply, custom branding, contract manufacturing, and white-label distribution across global markets. It is also compliant with regulations required for tenders, hospital procurement, ePharmacy listings, and wholesale distribution.

Patients prescribed OM-DOM CAP benefit from rapid relief of symptoms such as acid burn, gastric discomfort, burping, regurgitation, and postprandial nausea. The medication is generally well tolerated, although mild side effects such as dry mouth, headache, or diarrhea may occur. Long-term use, especially of Domperidone, should be monitored in elderly patients and those with cardiac conditions due to potential QT prolongation risk.